FAP and neoplasm: Hence, we hypothesized that a radioligand targeting FAP could be used for pretherapeutic estimation of FAP expression prior to local or systemic therapy in UC, which addresses the unmet need for appropriate pretherapeutic lymph node and distant metastases staging in this tumor entity.